Publication Date 01/07/2014         Volume. 6 No. 6   
Information to Pharmacists


From the desk of the editor

Welcome to the July 2014 homepage edition of i2P (Information to Pharmacists) E-Magazine.
At the commencement of 2014 i2P focused on the need for the entire profession of pharmacy and its associated industry supports to undergo a renewal and regeneration.
We are now half-way through this year and it is quite apparent that pharmacy leaders do not yet have a cohesive and clear sense of direction.
Maybe the new initiative by Woolworths to deliver clinical service through young pharmacists and nurses may sharpen their focus.
If not, community pharmacy can look forward to losing a substantial and profitable market share of the clinical services market.
Who would you blame when that happens?
But I have to admit there is some effort, even though the results are but meagre.
In this edition of i2P we focus on the need for research about community pharmacy, the lack of activity from practicing pharmacists and when some research is delivered, a disconnect appears in its interpretation and implementation.

read more
open full screen

Recent Comments

Click here to read...

Wind Farm will Power Sydney's Desalination Plant

Staff Writer

articles by this author...

Editing and Researching news and stories about global and local Pharmacy Issues

Source: AAP NewsWire

The wind farm set to power Sydney's desalination plant will begin operation this week and its owner Infigen Energy says similar projects will drive the company's growth.

The 67-turbine Capital wind farm, near Bungendore, east of Canberra, will be opened on Wednesday.

It will be the largest wind farm in NSW and is more than five times the size of any other wind farm in the state, Infigen says.

The wind farm has a capacity of 140.7 megawatts (MW) and its total output could power about 60,000 homes, although average output is expected to be slightly more than one third of full capacity.

Under a 20-year contract signed last year, the majority of Capital wind farm's output will be used by Sydney Water to power its desalination plant at Kurnell, in the south suburbs of Sydney.

Infigen managing director Miles George said the desalination plant would use 40MW of electricity when it began operating this summer, and that any left over power generated by the wind farm would go into the national electricity grid.

The opening marks a major milestone for Infigen, formerly known as Babcock & Brown Wind Partners until a management internalisation in April this year.

With four operational Australian wind farms on its books, another under construction and a further 12 in its project pipeline, the company says the federal government's renewable energy targets will be the main driver for its future growth.

A major component would also be the supply of power to major infrastructure such as desalination plants, George said.

"We expect that desalination plants will be a significant part of our business, going forward," he told reporters.

"It's expected that there will be half a dozen or so still to come around the country.

"From our point of view, having large long-term customers who, like Sydney Water, are seeking to operate their plants in a carbon-neutral fashion ... we think is a great prospect for our business."

Plans to sell Infigen's wind farm assets in the United States, Germany and France are continuing on track, George said.

The company intends to use the proceeds to pay down debt and focus primarily on the Australian renewable energy sector.

Infigen said in August the sale process was expected to take six months and possibly longer in the US.

"We are well into that process now, and the processes are going very well, there's no change to our timetable," George said.

"We mentioned at the outset that there was very strong interest from all three jurisdictions for those assets and that remains the case."

The company would provide a trading update for the financial year-to-date at its annual general meeting next week, he said.

Return to home

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options

This question is for testing whether you are a genuine visitor, to prevent automated spam submissions.
Incorrect please try again
Enter the words above: Enter the numbers you hear:

Clinical Newsfeed

health news headlines provided courtesy of Medical News Today.

Click here to

If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.

Subscribe to our mailing list

Email Format


  • Copyright (C) 2000-2015 Computachem Services, All Rights Reserved.

Website by Ablecode